Closing Date: 8 august 2008Nam Pharma Animal Health Sdn BhdA well-established company engaged in manufacturing and distributing veterinary pharmaceutical products. We share a vision that drives our growth and success. We have the mindset of striving for better quality, processes and product development for our customers in order to achieve our goals. In view of the expansion of our business, we in
The drug Gardasil--a vaccine from Merck & Co. Inc. manufactured to inoculate women against HPV and cervical cancer--is possibly killing women instead.According to the U.S. Center for Disease Control (CDC) website, the CDC's Vaccine Adverse Event Reporting System (VAERS) "is a national program of CDC and the Food and Drug Administration (FDA) that monitors the safety of vaccines after they are
Even though medical marijuana is still illegal in most places, pharmaceutical companies are busily applying for -- and in many case, have already received -- multiple patents for medical marijuana drugs.
These include patents for synthetic derivatives (such as the oral THC pill Marinol), cannabinoid agonists (synthetic agents that bind to the brain's endocannabinoid receptors, such as HU-210) and
Plethico Pharma operates in the fast-growing herbals & nutraceuticals segments.The stock is an attractive investment pick in a bearish market
Beta: 0.2
Institutional Holding: 6.2%
Dividend Yield: 0.6% P/E: 9
M-Cap: Rs 1,309 cr
CMP: Rs 384.3
EVEN WHILE the Sensex has been falling, there are promising stocks which offer both growth and value to investors and provide a hedge against the curren
Qualification: B.SC.Pharma, MBA
Experience: 2 - 5 years
Location: Mumbai
Job Description -
Making / Helping in making presentation by ensuring required data
been extracted
Assisting in conducting orientation program for the marketing and
sales team on better usage of MIS
Assisting in carry out primary market research to address critical
Marketing issues
Timely and comprehensive response to
SGH
Pharmacist
visit : www.sgh.com.sg/careers
And other jobs:
Pfizer
Regulatory Affairs Executive
fax : 03 5568 6610
Genzyme
Rep
email : recruitment.apac@genzyme.com
Please quote 101 Global Jobs (Healthcare) in your application to this job!
To receive job announcements in your e-mail on a daily basis, subscribe to 101globaljobs-subscribe@yahoogroups.com.
Bafna Pharma IPO Allotment Status is out and can now be checked online. To know the allotment status of Bafna Pharma IPO keep your IPO application number in your hand and visit the registrar’s website. Select Bafna Pharma IPO and click go. Now enter your application number to check the Bafna Pharma IPO Allotment Status [...]
Bafna Pharma IPO allotment Status is ready and can be checked here :
addthis_url = 'http%3A%2F%2Fwww.rupya.com%2Farchives%2F2008%2F06%2F23%2Fbafna-pharma-ipo-allotment-status%2F';
addthis_title = 'Bafna+Pharma+IPO+allotment+Status';
addthis_pub = '';
Fundamentally a very sound company, the financial performance has been, as expected, very good.
Net sales of the company rose 8.25% at Rs.2435.90 crores. Operating expenses grew consistently: EBITDA was up 24% at Rs.435.36 crore. PBT was up 41% at Rs.291.75 crore. And despite an over 12 times rise in taxation outgo, the company posted a PAT of Rs.238.48 crore; a 19% rise over previous year.
The
Name: ajitQ: is b-pharm with mba in marketing is agood option ?what are the jobs that can be applied on this qualification ?what is the pay scale for product management team career or as a प्रोडक्टmanager in a pharma industry ?
Experience: 2 - 3 Years
Location: Delhi/NCR
Compensation: Rupees 2,25,000 - 2,75,000
Candidates must be based in Delhi NCR & have good HR Experience in Pharma industry.
Education: UG - B.B.A - Management
PG - MBA/PGDM - HR/Industrial Relations
Industry Type: Pharma/ Biotech/Clinical Research
Functional Area: HR / Administration, IR
Posted Date: 08 Jun
Job Description
To handle HR function
Sun Pharma has completed the purchase of dosage form manufacturing operations of US based Able Labs for $23.15 million (Rs 104.17 crore) through its wholly-owned subsidiary company, Sun Pharmaceutical Michigan.Now the ownership and lease rights to manufacturing operations at two sites in New Jersey, and special suites for manufacturing controlled substances, spread over an area of 275,000 sq ft. l
As we continue to celebrate our recent acquisition of ReceptoPharm, I would like to take a moment and welcome Dr. Paul Reid and Mr. Harold Rumph to the Nutra Pharma Board of Directors.
For the past several years, I have had the pleasure of working closely with both Dr. Reid and Mr. Rumph at ReceptoPharm. Their [...]
Pfizer
Rep based Klang/Kuantan/ Penang/Kuching/ KK
Regulatory Affairs Exec
fax to : 03 55686610
Summit
Rep based PJ/Butterworth
snail mail to :
Sales and Marketing Manager
Consumer Division
Summit Co (M) Sdn Bhd
Lot 6, Jln 19/1, 46300 PJ.
Zuellig
Key Account Executive/Superviso r
Rep based Klang/Mlk/Seremban
CRO
email : apply@zuelligpharma.com
Please quote 101 Global Jobs (Healthcare) in your
With dems (notably Obama) constantly declaring war on every major business that make our lives better I think it's appropriate to debunk some of dems attacks on our pharmaceutical industry:
Time to develop and market a new drug: 10-15 years
Average Cost to develop a new drug (2006): $1.318 billion
Total R&D spending on drugs in 2007: $58.8 billion
Generic share of market in 2007:...
Click
Sun Pharma, India's largest pharma company by market capitalization has failed to clinch the deal for Israeli major Taro Pharma. The merger deal, signed on May 18, 2007, stipulated a price of $7.75 per share to be paid by Sun to acquire Taro, with either of the parties having freedom to terminate the agreement after December 31, 2007. Now, Taro has rejected Sun's revised offer of $10.25 per share
Buy : Divis Laboratories CMP : Rs 1397 Target : Rs 1540 Upside : 10% Stop Loss : Rs 1365Time Frame : 5-7 Days If the investors wants some different pharma pick may be Divis Labs would be the best for short term Investor Pick. Divis Lab made a low of 1369 in past two days which is almost a double bottom which act as a great support. To be more precise can make a stop loss of 1365 and can tak
Zandu PharmaRecommendation Price - 6679.75Target Price - 8000Recommendation Date - 13-Nov-2007Recommendation Type - Long TermToday's High Price - 8220.10Target Achieved in 196 daysTarget Achieved Date - 27-May-2008Annual Gain - 43.06%Actual Gain - 23.06%www.vjondalalstreet.com/marketma.php
Pharmaforte
Rep based PJ/Penang
email: carmenchiang@pharmaforte.com.my
GSK
Medical Affairs Manager
email: teddy.l.ruiz@gsk.com
Caring Pharmacy
Pharmacist
email : hfwong@caringpharmacy.com.my
Bio Life
Sales Manager
Rep
email : HR@biolife.com.my
BI
Rep based JB/Subang
email : ainura@kul.pharmaton.com
Please quote 101 Global Jobs (Healthcare) in your application to this job!
To receive job
US HOT STOCKS: Esmark, Jazz Tech, United Natural Foods -3-
Last Update: 5/20/2008 12:06:35 PM
Among the companies seeing active trade in Tuesday’s session are Home Depot Inc.
(HD), Microsoft Corp. (MSFT), Yahoo Inc. (YHOO), Fannie Mae (FNM), and Freddie
Mac (FRE).
Home Depot Inc. (HD, $27.39, -$1.48, -5.13%), the largest U.S. home-improvement
retailer, said its first-quarter net income fell
Bafna Pharmaceuticals IPO - Bafna Pharma public issue of 64,00,000 equity shares of Rs 10 each at a price of Rs 40 per equity share (including share premium of Rs 30 per equity share) for cash aggregating Rs 25.60 crores will open for subscription on May 27, 2008 and will close on May 30, [...]
Bafna Pharmaceuticals IPO is scheduled to open for subscription on May 27, 2008. It is a fixed price IPO. IPO price has been fixed at Rs. 40 per share of face value Rs. 10 each. The public issue opens for subscription on Tuesday, May 27, 2008 and will close for subscription on May 30, 2008. [...]
>Torrent Pharmaceuticals has declared its results for the quarter ended March 2008 (Q4). The company’s revenue was down by 5% to Rs 320 crore versus Rs 337 crore.
>Century Enka has announced its results for the quarter ended March 2008 (Q4). The company registered a net loss of Rs 80 lakh versus profit of Rs 1.38 [...]
Solvay Pharma India net profit rose 65.16% to Rs 6.59 crore in the Qtr Ending Mar 2008 compared to Rs 3.99 crore in the Same Qtr YOY. Sales rose 14.07% to Rs 39.96 crore in the Qtr Ending Mar 2008 compared to Rs 35.03 crore in the Same Qtr YOY.
addthis_url [...]
Connecticut Attorney General Richard Blumenthal has asked for help against influence wielded by drugmakers in formal testimony before the state’s Legislature.
Blumenthal wants to make it illegal for drugmakers to give gifts or other benefits to physicians, citing it may influence their health care decisions despite a code of ethics the industry has already adopted.
In his view, the current code is meaningless and unenforceable. Drug companies spend more than $11 billion per year on relentless direct marketing of their drugs.
Specifically, Blumenthal proposes that Connecticut law:
Prohibit any gifts, scholarships or other items in exchange for prescribing products, a commitment to continue prescribing products or to otherwise interfere with the independence of a health care provider’s
Parallel traders are the thorn in the side for pharmaceutical companies operating in Europe. Local sales mangers see their bottom line eroded as independent exporters undercut them with their own product! The considerable efforts that pharma companies have gone to prevent this grey trade have largely failed. The majority of legal actions against traders [...]
Merck & Co. conducted its own studies on the pain pill Vioxx, then hired companies to ghostwrite reports for medical journals that appeared under the names of scientists who didn't do the majority of the research, court records show. In many cases, Merck's involvement in producing the data wasn't disclosed, according to two articles in the current Journal of the American Medical Association relying on court papers. The documents disclosed by Merck in two Vioxx lawsuits also suggest the company's control of the data allowed it to downplay the risk of death from Vioxx in patients with Alzheimer's disease, the journal's editors said in an editorial. About 250 documents show Merck employees worked alone or with publishing companies to write manuscripts and later recruited academic medical expe
Ankur Drugs & Pharma net profit rose 144.31% to Rs 19.96 crore in the Quarter Ending March 2008 compared to Rs 8.17 crore during the Prev QTR YOY 2007. Sales rose 136.80% to Rs 207.51 crore in the Quarter Ending March 2008 compared to Rs 87.63 crore during the Prev QTR YOY 2007.
addthis_url [...]
Free Intraday Tips for 15th April 08SASKEN ( Sasken Communication Technologies Ltd) ActionTrigger Price Stop LossTarget 1 Target 2BUY ABOVE138135144153S.SELL BELOW132136127118Click here for more recommendations of stocks below Rs.150 ANKURDRUGS ( Ankur Drugs And Pharma Limited) ActionTrigger Price Stop LossTarget 1 Target 2BUY ABOVE210204219229S.SELL BELOW201206195178SELAN ( Selan Exploration Technology Ltd) ActionTrigger Price Stop LossTarget 1Target 2BUY ABOVE188182198210S.SELL BELOW179183171153Read more... Did You Enjoy this Post?Subscribe Today.
Click here for more recommendations of stocks below Rs.150
Click here to Get Tips for your own Stocks
Orchid Chemicals & Pharmaceuticals Ltd has informed the market that the Company is announcing, on April 10, 2008 the formation of its wholly owned subsidiary in Japan called Orchid Pharma Japan K K (Orchid Japan). Orchid Japan, is headquartered in Tokyo, will drive Orchid’s foray into the high potential and growing Japanese generics market.
[...]
After talking to a number of shareholders, it has become apparent that many of you haven’t seen our video from Business & Beyond. This short six-minute presentation offers a great overview about us and our drug discovery and medical devices subsidiaries, ReceptoPharm and Designer Diagnostics.
In the future, we are going to be posting our videos [...]
According to The Deal’s recent interview with Dr. Matt Higgins, Management Professor at Georgia Institute of Technology, big pharma’s need to acquire new technology is increasing. He explains that expanded competition from generics and internal productivity issues with research not pumping out as many new drugs are to blame. What could potentially be viewed as [...]
Social media are shifting the way that the global economy operates. Internet journals and communities have enabled consumers to communicate their experiences with companies’ products and services to other consumers. A consequence of consumer-generated marketing is that relationship management throughout the lifecycle of a product is taking the place of mass marketing in consumer-driven industries.
Scope [...]
Faced with dwindling growth rates in the US and Europe, pharmaceutical companies are turning their attention towards emerging pharmaceutical markets whose double-digit growth is fuelled by their recent economic booms. However, although the patient potential of the emerging market countries is enormous, foreign pharma companies are currently tapping into only a fraction of the consumers, [...]
Cardiome Pharma (NASDAQ: CRME) picked a bad day for good news. According to the AP the company announced "interim midstage data showed its experimental drug...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Carl Icahn filed a 13D regarding his stake in Enzon Pharmaceuticals (ENZN) today.
Icahn now may be deemed to beneficially own, in the aggregate, 3,072,103 Shares, representing approximately 6.93% of Enzon's outstanding Shares (based upon the 44,322,923 Shares
Also,
"The Reporting Persons have entered into a number of derivative agreements, commonly known as Total Return Swaps, with counterparties, which agreements provide that the profit to the Reporting Persons shall be based upon the...
Continued at Todd Sullivan's ValuePlays
This fascinating article looks at Progressive Malpractice (ignoring the fundamental economic and political roots of a crisis) and Libertarian Narcissism (promoting individual solutions for collective problems.)
Mainstream medical practitioners, the corporate media, and elected public officials ignore or cover-up the real problems with our health. Band-aid solutions are offered, but with Big Pharma spending more on lobbying than any other industry in the United States, real solutions seem unlikely to come from politicians. The result? American consumers and employers will spend over two trillion dollars this year on health insurance, pharmaceutical drugs and medical bills, while remaining among the unhealthiest people on Earth.
The author argues that even universal health care is not enough
This fascinating article looks at Progressive Malpractice (ignoring the fundamental economic and political roots of a crisis) and Libertarian Narcissism (promoting individual solutions for collective problems.)
Mainstream medical practitioners, the corporate media, and elected public officials ignore or cover-up the real problems with our health. Band-aid solutions are offered, but with Big Pharma spending more on lobbying than any other industry in the United States, real solutions seem unlikely to come from politicians. The result? American consumers and employers will spend over two trillion dollars this year on health insurance, pharmaceutical drugs and medical bills, while remaining among the unhealthiest people on Earth.
The author argues that even universal health care is not enough
About Aurobindo Pharma
One of the largest API manufacturers in Asia, Aurobindo Pharma has commercialised over hundred APIs. Aurobindo’s products are spread over six major areas encompassing Antibiotics, Anti-Retro Virals, CVS, CNS, Gastroenterologicals, and Anti-Allergics.
Aurobindo’s R & D strengths lie in developing intellectual property in non-infringing processes and resolving complex chemistry challenges. In the process, Aurobindo [...]
The service of PSD502 in the service of the treatment of untimely ejaculation.May 2007, Sciele signed an licensing concord in the service of PSD502 with Plethora Solutions.PSD502 is a proprietary formulation of two marketed drugs - lidocaine and prilocaine - dispensed by a metered administer aerosol and developed in the service of the treatment of untimely ejaculation, a disorder affecting up to 30% of men in Europe and the U.And in the service of which there currently is no FDA-approved medication treatment.Offering is applied locally when needed ( continually referred to as "on demand" therapy) and is serviceable within five minutes.Offering has been shown to dilate ejaculation latency duration whenpared with placebo in a multi-center wind up II investigation This figures was published
2007 turned out to be a great year for Nutra Pharma. We had a lot of exciting developments and now that we are finally settled into 2008, I felt it was appropriate to review some of them…
Drug Discovery
We initiated a Phase IIb/IIIa clinical trial for the treatment of Adrenomyeloneuropathy and successfully completed our 6-month patient [...]
By Shailendra BhatnagarFeb. 28 (Bloomberg) -- India's benchmark Stock Exchange moved between gains and losses today.Sun Pharmaceutical Industries Ltd., India's biggest drugmaker, gained after saying it won U.S. approval to sell its version of Roche Holdings AG's Demadex for the treatment of edema.The benchmark Sensex rose 3.46, or 0.02 percent, to 17,829.45 as of 10:05 a.m. local time in Mumbai on the last day of the expiry of monthly derivatives contracts and a day ahead of the presentation of the budget for the financial year to March 2009. The measure had advanced 2.8 percent in the past three sessions.Sun Pharmaceutical Industries Ltd. gained 9.45 rupees, or 0.8 percent, to 1,202.1. Housing Development Finance Corp., the mortgage lender partly owned by Citigroup Inc. gained for a third
It’s been a while since we last wrote on our Blog, but after several months redeveloping our Website, we are back and ready to keep the posts rolling.
For those of you who aren’t familiar with us, we are a biotech company based in Boca Raton, Florida. We’re developing treatments for neurological and autoimmune disorders, including [...]
About 90 percent of the pharmaceutical industry’s $21 billion marketing budget is directed at physicians, according to JAMA. There are more than 90,000 pharmaceutical representatives that visit U.S. physicians, providing free lunches, gifts, marketing paraphernalia and free medication samples. These enticements are designed to influence doctors to prescribe more drugs and more expensive drugs and have often become a substitute for objective medical evidence.Launched in 2002, AMSA’s PharmFree Campaign encourages medical schools and academic medical centers to develop policies that limit the access of pharmaceutical company representatives to their campuses and prohibit medical students and physicians from accepting gifts of any kind from these representatives. In May 2007, AMSA released its PharmFree Scorecard, which was a first-of-it’s-kind ranking of medical schools according to their pharmaceutical influence policies.Of all the medical schools in the United States, five receive
Pressured by drug regulators from around the world, Bayer announced today that it had agreed to withdraw its controversial heart surgery drug Trasylol after a Canadian study found that it may increase the risk of death.
The Food and Drug Administration asked the company to suspend sales of the drug, which is used to stem excessive bleeding during heart surgery, until it has been able to conduct a thorough examination of the full results of the Canadian study.Sources:New York Times November 5, 2007
Shares of Momenta Pharma (MNTA) are off 46% to $7.27, a 52-week low. The company said said Tuesday...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
About 90 percent of the pharmaceutical industry's $21 billion marketing budget is directed at physicians, according to JAMA. There are more than 90,000 pharmaceutical representatives that visit U.S. physicians, providing free lunches, gifts, marketing paraphernalia and free medication samples. These enticements are designed to influence doctors to prescribe more drugs and more expensive drugs and have often become a substitute for objective medical evidence.
Launched in 2002, AMSA's PharmFree Campaign encourages medical schools and academic medical centers to develop policies that limit the access of pharmaceutical company representatives to their campuses and prohibit medical students and physicians from accepting gifts of any kind from these representatives. In May 2007, AMSA released its PharmFree Scorecard, which was a first-of-it's-kind ranking of medical schools according to their pharmaceutical influence policies. Of all the medical schools in the United States, five recei
Market scaled to new height of 20000 mark. Day trading recommendations gave tremendous returns like NTPC gave a return of RS 9 and Airtel gave a return of Rs 21.
Hope you all have made money with our suggestions
Buy Torrent Pharma > 164.1,165.6,169.6,172 Stop loss 161.5
Buy Glenmark > 454.1,465,479
Abbi Adest of Seeking Alpha gave us a great report on four foreign companies that are going public this week. Giant Interactive Group (GA), Scope Metals (SCPE), Akela Pharma (AKLA), and CNinsure (CISG)
Giant Interactive Group (GA) is a Chinese online game developer and operator with Total Revenue in the 6 months ending June 30, 2007 of about $90.3M and Net Income of $67.3M. They will be selling 57.2 million shares at $12.00 - $14.00 per share.
Scope Metals (SCPE)is an Israeli based distributor and supplier of finished and semi-finished m
Momenta Pharmaceuticals leverages its proprietary technology to unlock the structural secrets of complex sugars and other complex mixtures. Unique tools and approach to drug development have yielded a diversified product pipeline consisting of technology-enabled generic drugs, re-engineered drugs and novel drug candidates.Sugars play a critical role in both normal biological processes and disease Sugars, together with DNA and proteins, play a critical role in regulating biological processes and pathways throughout the human body. This makes sugars a fertile field for research and provides significant opportunity for discovering improved treatments for many diseases. To date, science has just begun to appreciate the profound role that sugars play in human biology. However, what we have learned so far is clear: The manner in which a cell produces sugars is critical for normal cell function and communicationMalfunctions in complex sugar production (and the resulting abnormalitie
What if the Military had disclaimers like Pharma Ads?
What if the military had to provide disclaimers in its ads in the same way that drug companies have to provide disclaimers about possible side effects? Probably nothing. Being in the military is just so appealing.
glumbert - What if the Military had disclaimers like Pharma Ads?
Elder Pharma Buys 51% In Biomeda Of BulgariaMumbai-based Elder Pharmaceuticals has acquired 51% stake in Biomeda Group in Bulgaria for euro 5 million (around Rs 28 crore) in an all-cash deal. Biomedia has a turnover in the range of euro 10-12 million.With the acquisition, Elder will see the launch of many more products in Europe. Biomeda is Elder’s second acquisition in less than 45 days. Earlier, Elder bought 20% stake in London-based NeutraHealth through subscription of shares worth about Rs 47 crore."Biomeda is an unique acquisition. It is a manufacturer of oral dosage formulations. The acquisition will provide us the right entry vehicle to enter the Bulgarian market, leveraging Elder’s robust EU product portfolio and pipeline. Elder will enjoy a pan-European presence, covering all the key markets of Europe," said Alok Saxena, director (international), Elder."The Bulgarian market's skilled labour, which has an advantage in terms of lower labour cost compared to other European c
Ninety-two percent of FDA advisory meetings in the last decade included a member with financial ties to drug companies. A look at how that affects the drugs that are allowed on the market -- even after they're shown to be deadly.
They're just dropping like Chinese imports -- prescription drugs that turn out to be deadly after FDA approval.
AlterNet August 28, 2007
Amgen Inc. (NASDAQ:AMGN) did what Wall Street thought it would in its after-the-bell conference...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Recent figures show that the global generics market grew by 20% in 2005 – three times the amount by which the pharma sector grew, and four times the growth of patented drugs. In fact, Cygnus predicts continued growth for the sector in the next five years, forecasting a CAGR of 13.62% for 2006-2010.
Analysts have identified [...]
Close examination of the pharmaceutical industry at present reveals a fairly troubled patient. The symptoms have gradually been deteriorating; drug development costs are soaring, R&D pipelines have yielded limited returns resulting in a steady drop in the number of product launches, and generic competition has intensified. At the same time, patent expiries have hit hard, [...]
Soeben ist in den USA eine neue Healthcare-Seite an den Start gegangen. Sie heißt “Who Is Sick?” und könnte sich als Internet-Startseite für alle Hypochonder etablieren.
Im Ernst: “Who Is Sick?” basiert auf user-generated-content und ist so was wie eine Gemeinschaftsplattform für allgemeines Unwohlsein. Heißt: User können via “Who Is Sick?” checken, ob sich andere Menschen [...]
The endless text of pharma disclaimers is at home on the Web. Web sites are getting pharmaceutical marketers' interactive budgets this year, according to a new study by the Medical Broadcasting Company (MBC) and CBI Research.A plurality of pharma marketers said site spending would be most likely to get their budgets this year. Far fewer respondents listed search engine marketing as a top budget priority. That is at odds with a recent comScore Networks study indicating that search is the main way that people develop brand awareness for pharmaceuticals.Brand awareness is only one of the goals a Web site accomplishes, however. Given that most people are looking for health information first and foremost when visiting a site, the focus on sites over search makes sense.Despite consumers' reliance on search engines to locate health information, some marketers are also leaving search campaigns to their competitors while concentrating on display ads, according to Jack Barrette of Yahoo!It is
(Posted by Patrick Sullivan Jr.)
Encouraging news for the future of conventional medicine over at PharmaGossip:Vision: AMSA [The American Medical Students Association] envisions a day when pharmaceutical companies are able to dedicate their resources to creating drugs that physicians choose to use because they are effective in treating disease, not because they are effectively marketed. We envision a day when every medical student and physician is aware of the professional, ethical and practical complications of the current relationship with pharmaceutical company representatives. We envision a day when physicians demand integrity, honesty, and education (not biased information) from members of their profession, for the sake of our patients and their trust in us.
Mission: Our mission in 2006 is to encourage medical schools and academic medical centers to develop policies that limit the access of pharmaceutical company representatives to their campuses and prohibits medical students a
Pharma Kontor ist die europäische Traditionsapotheke im Internet mit den konsequent günstigen Preisen. Die beliebtesten Medikamente Europas im Sortiment. Ersparnis bis zu 40%. Pharma Kontor - Die Discount Apotheke. Medikamente müssen nicht teuer sein. Ohne Rezeptgebühr. Versandkostenfrei.
